Pharma bribery corrupts health care, puts patients at risk, new review warns
Kickbacks, sham studies and regulatory payoffs distort prescribing and drug approvals
Sham clinical studies, slush funds, luxury gifts, and shell companies: A new review shows how pharma firms allegedly bribed their way to drug approvals and sales.
